Literature DB >> 3372683

Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary?

W M Hout1, B M Arafah, R Salazar, W Selman.   

Abstract

Patients undergoing pituitary adenomectomy are usually given glucocorticoid therapy, although there are no data to document the need for such therapy. We prospectively studied hypothalamic-pituitary-adrenal axis (HPA) function in 88 consecutive pituitary adenoma patients before and after selective adenomectomy, excluding those with corticotroph adenomas. Preoperatively, 5 patients had adrenal insufficiency (AI); they were treated with glucocorticoids and excluded from the analysis. The remaining 83 patients had normal HPA function preoperatively and were not given glucocorticoids before, during, or immediately after surgery, but were closely monitored, and their serum cortisol levels were measured in the immediate postoperative period. Two patients were clinically suspected to have AI postoperatively and were treated accordingly. The remaining 81 patients had no clinical manifestations of AI and received no glucocorticoid therapy. Their serum cortisol levels in the immediate postoperative period were appropriately elevated. The mean serum cortisol level was 40.5 +/- 11.1 (+/- SD) micrograms/dL (1117 +/- 306 nmol/L) 6 h after surgery; serum cortisol levels decreased gradually thereafter. Morning serum cortisol levels were within the normal range on the fourth, fifth, and sixth days after surgery: day 4, 15.1 +/- 7.0 micrograms/dL (417 +/- 193 nmol/L); day 5, 16.4 +/- 5.6 micrograms/dL (453 +/- 155 nmol/L); and day 6, 16.3 +/- 5.7 micrograms/dL (450 +/- 157 nmol/L). When tested 3 months after surgery, all 81 patients had normal HPA function. We conclude that HPA function is rarely compromised after selective pituitary adenomectomy. Close observation and serum cortisol measurements in the immediate postoperative period can reliably predict the integrity of the HPA after surgery. Routine glucocorticoid therapy is not needed in patients undergoing selective adenomectomy whose preoperative adrenal function is normal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372683     DOI: 10.1210/jcem-66-6-1208

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors.

Authors:  Nicholas F Marko; Amir H Hamrahian; Robert J Weil
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

2.  The impact of peri-operative dexamethasone administration on the normal hypothalamic pituitary adrenal response to major surgical procedures.

Authors:  Katia El-Sibai; Aman Rajpal; Ribal Al-Aridi; Warren R Selman; Baha M Arafah
Journal:  Endocrine       Date:  2017-09-01       Impact factor: 3.633

3.  Value of serum dehydroepiandrosterone sulfate assay in the evaluation of pituitary-adrenal insufficiency after pituitary adenomectomy.

Authors:  B Ambrosi; D Bochicchio; S Peverelli; R Ferrario; G Faglia
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

4.  Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas.

Authors:  R Cozzi; G Lasio; A Cardia; G Felisati; M Montini; R Attanasio
Journal:  J Endocrinol Invest       Date:  2009-04-29       Impact factor: 4.256

5.  The postoperative cortisol stress response following transsphenoidal pituitary surgery: a potential screening method for assessing preserved pituitary function.

Authors:  Gabriel Zada; Amir Tirosh; Abel P Huang; Edward R Laws; Whitney W Woodmansee
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

6.  Thoracic stimulation and prolactin secretion.

Authors:  L P Kapcala; M C Lakshmanan
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

Review 7.  Postoperative assessment of the patient after transsphenoidal pituitary surgery.

Authors:  John C Ausiello; Jeffrey N Bruce; Pamela U Freda
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

8.  Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas.

Authors:  M Marazuela; B Astigarraga; A Vicente; J Estrada; C Cuerda; J García-Uría; T Lucas
Journal:  J Endocrinol Invest       Date:  1994-10       Impact factor: 4.256

Review 9.  Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis.

Authors:  Mamatemin Tohti; Junyang Li; Yuan Zhou; Yuebing Hu; Zhuang Yu; Chiyuan Ma
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 10.  How should we interrogate the hypothalamic-pituitary-adrenal axis in patients with suspected hypopituitarism?

Authors:  Aoife Garrahy; Amar Agha
Journal:  BMC Endocr Disord       Date:  2016-06-17       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.